[{"Assets_0_Q2_USD":"12128300000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.23","CommonStockSharesConverted_0_Q2_shares":"136500000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.44","EarningsPerShareBasic_2_Q2_USD":"1.23","EarningsPerShareDiluted_1_Q2_USD":"0.44","EarningsPerShareDiluted_2_Q2_USD":"1.22","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"462700000.0","NetIncomeLossConverted_1_Q2_USD":"60600000.0","NetIncomeLossConverted_2_Q2_USD":"167000000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q2_USD":"1219100000.0","RevenuesConverted_2_Q2_USD":"2560100000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"5910900000.0","StockholdersEquity_0_Q2_USD":"5910400000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"137500000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"137300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"136400000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"136300000.0","filed":"20200805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"PERRIGO CO PLC","period":"20200630","qtrs":"1","uom":"USD"}]